Fig. 5From: Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysisCost-effectiveness acceptability curve (US$3780 and US$5880 denote the willingness-to-pay thresholds calculated by Ochalek [46], while US$8840 is the GDP per capita in 2017, China)Back to article page